GC
IPOs - All articles
-
Ngie returns to UBS for Greater China corporate finance job
UBS has created a new corporate finance group within the Greater China team that will mainly focus on the execution of IPOs, according to an internal memo seen by GlobalCapital Asia.
-
Chinese companies jump into thriving quarter-end HK IPO market
China’s Archosaur Games set in motion its HK$2.17bn ($280.5m) IPO on Tuesday, joined by Cathay Media and Education Group and poultry producer Shandong Fengxiang.
-
Bohai Bank launches chunky Hong Kong IPO
China Bohai Bank has jumped into Hong Kong’s bustling IPO market, opening books for a HK$14.3bn ($1.85bn) listing.
-
SMIC’s stock soars after Star listing approved
The Hong Kong-listed shares of Semiconductor Manufacturing International Corp (SMIC) opened higher on Tuesday after the company got the nod from the Chinese securities regulator to list on the Star board.
-
Chinese property trio build Hong Kong listings
Property managers Greentown Management Holdings and Zhenro Services Group launched bookbuilding on Monday for Hong Kong Stock Exchange IPOs.
-
OcuMension, Immunotech Bio launch IPOs
OcuMension Therapeutics hit the market on Monday with its HK$1.55bn ($200m) IPO, the latest in a stream of healthcare sector listings on the city’s stock exchange.
-
Asia-targeted Spacs seek US listings
Two Asia-focused special purpose acquisition companies (Spacs) are looking to list on the US stock market.
-
E-cigarette maker Smoore draws demand for $919m IPO
Smoore International Holdings, the world’s largest vaping device manufacturer by revenue, has opened books for a HK$7.12bn ($919m) IPO.
-
Hong Kong IPO hopefuls pile in applications
A host of Chinese issuers filed IPO applications with Hong Kong’s stock exchange this week as they rushed to get their documents in before the end of the quarter.
-
Zhenro Services gets HKEX nod for IPO
Property management company Zhenro Services Group is set to list in Hong Kong after getting the nod from the city’s stock exchange listing committee.
-
Sri Trang pockets $281m from hot Thai listing
Sri Trang Gloves priced its Bt15bn ($481.4m) Thai IPO at the top of the range this week, taking advantage of coronavirus-driven demand, strong international interest and a liquid domestic equity capital market. Jonathan Breen reports.
-
Hepalink Pharma kicks off $585m Hong Kong listing
Shenzhen Hepalink Pharmaceutical Group launched its Hong Kong IPO this week, targeting proceeds of HK$4.53bn ($585m).
-
First 32 firms seek new style ChiNext IPOs
China’s ChiNext board, which focuses on innovative companies and start-ups, has started accepting listing applications as it kicks off a reform centred on a registration-based IPO system.
-
Thai glove maker Sri Trang to raise $481m from IPO
Thai rubber glove maker Sri Trang Gloves is set to raise Bt14.9bn ($481.4m) from its IPO, capitalising on a surge in demand for its products caused by Covid-19.
-
Agora logs in for $315m Nasdaq listing
Agora is looking to raise up to $315m from its Nasdaq IPO, having begun bookbuilding for the deal.
-
SK Biopharma pockets W959bn from IPO
Drug developer SK Biopharmaceuticals priced its IPO high last Friday, netting W959.3bn ($792m), according to a source close to the deal.
-
Kangji, Hygeia Healthcare price Hong Kong IPOs high
Kangji Medical Holdings has bagged HK$3.59bn ($464.2m) after pricing its Hong Kong listing at the top of the marketed range.
-
Hygeia Healthcare to price $286m IPO high
Hygeia Healthcare Holdings is on track to price its Hong Kong IPO at the top of the marketed range, according to a source close to the deal.
-
Greentown Management nears Hong Kong IPO launch
Greentown Management Holdings Co has uploaded post-listing hearing documents with Hong Kong’s stock exchange as it prepares to launch its IPO.
-
Korean gaming firm DoubleDown readies $209m US listing
Online casino gaming company DoubleDown Interactive has set the terms for its Nasdaq IPO, preparing the first South Korean listing on a US bourse in nearly a decade.
-
China Pacific Insurance IPO revives London Stock Connect
China Pacific Insurance (Group) Co became the second company to use the London-Shanghai Stock Connect scheme this week, listing Global Depository Receipts on London’s bourse. The deal could spur further London-bound issuance by Chinese firms, according to bankers in the UK and Asia. Jonathan Breen and Aidan Gregory report.
-
Ebang International mines for IPO demand
Ebang International Holdings, a Chinese cryptocurrency mining hardware maker, has kicked off its IPO of up to $125.6m on Nasdaq in the US.
-
Pacific Insurance prices $1.8bn London float of GDRs
China Pacific Insurance (Group) Co has raised $1.81bn from its listing of Global Depository Receipts, becoming just the second company to use the London-Shanghai Stock Connect scheme.
-
Yum China meets banks for secondary Hong Kong IPO
Fast food restaurant franchiser Yum China Holdings is in the process of mandating banks for a secondary listing in Hong Kong, according to sources familiar with the matter.
-
ESR targets $800m from 2020 Korea Reit IPO
ESR Cayman, a warehouse construction firm and lessor, is planning to list a real estate investment trust (Reit) in South Korea later this year, according to a source close to the transaction.
-
Genetron kicks off $176m US IPO, follows oncology trend
China’s Genetron Holdings has launched bookbuilding for its Nasdaq listing, according to a source familiar with the matter.
-
Hygeia Healthcare launches $286m IPO as HK market heats up
Hygeia Healthcare Holdings has kicked off the roadshow for its up to HK$2.22bn ($286.4m) IPO, joining Hong Kong’s increasingly hot listing market.
-
Ninebot to list China’s first CDRs on Star
Ninebot, an electric scooter producer backed by electronics giant Xiaomi Corp, has won approval to raise more than Rmb2bn ($282m) from listing China Depository Receipts on the Star board.
-
Kangji Medical launches $404m Hong Kong IPO
Kangji Medical Holdings kicked off bookbuilding for its Hong Kong listing on Monday, aiming to raise up to HK$3.12bn ($404m) in proceeds.
-
Burning Rock’s US stock surges after $223m IPO prices high
Burning Rock Biotech, a Chinese cancer treatment firm, raised $222.8m from its US listing last Friday. The issuer's stock soared nearly 50% on its debut, after the IPO was priced above the initial guidance.
-
Pacific Insurance takes next step with London GDR listing
Shanghai-based China Pacific Insurance (Group) Co has launched its IPO on the London Stock Exchange, firming up the deal size and the syndicate group on the listing. The deal was covered on Friday, its first day of bookbuild.
-
HK-listed Weigao plans Star market spin-off
Shandong Weigao Group Medical Polymer Co is looking to spin off and list its orthopaedic business on Shanghai’s Nasdaq-style Star market.
-
Simcere Pharmaceutical eyes Hong Kong listing
China’s Simcere Pharmaceutical Group is seeking the green light to float on Hong Kong’s stock exchange after filing a listing application with the bourse.
-
IPO hopefuls rush for approval as second half looms
Hong Kong’s IPO market is gearing up for a busy few weeks as companies push for listing approvals before the end of June, with bankers and investors remaining bullish on the city’s stocks. Jonathan Breen reports.
-
Jiangxiaobai eyes $1bn from Hong Kong IPO
Jiangxiaobai is planning to list in Hong Kong this year, according to a source close to the deal.
-
JD.com to pocket $3.9bn from bumper HK listing
Chinese e-commerce company JD.com is set to raise HK$30.1bn ($3.87bn) from its Hong Kong secondary listing, according to a source familiar with the matter.
-
SK Biopharma kicks off Korea’s first 2020 IPO
SK Biopharmaceuticals has begun bookbuilding for its up to W959.3bn ($804.9m) IPO. It is set to be South Korea’s first listing in 2020.
-
Bohai Bank awaits HKEX nod for billion-dollar IPO
Bohai Bank’s Hong Kong IPO application was being considered by the stock exchange’s listing committee on Tuesday, according to a source close to the deal.
-
SSE loosens Star listing rules for red-chip companies
The Shanghai Stock Exchange has clarified rules around red-chip companies listing on the Star board, shedding light on some areas that have previously confused bankers in China.
-
Updated: Cancer treatment firm Burning Rock kicks off $209m US IPO
Burning Rock Biotech, a cancer detection and therapy company, has opened books for its up to $209.3m Nasdaq IPO following a hot week for Chinese listings in the US.
-
JD.com covers $3.8bn Hong Kong secondary listing
Chinese e-commerce company JD.com covered its Hong Kong secondary listing within a few hours of opening bookbuilding late last Friday evening, with orders continuing to pour in on Monday.
-
NetEase wins $2.7bn from HK secondary listing
Chinese online game developer NetEase has raised HK$21.1bn ($2.7bn) from its secondary offering in Hong Kong, riding on strong investor support for its listing, according to a senior banker on the deal.
-
JD.com readies $3bn Hong Kong listing
Chinese e-commerce company JD.com will open books for its Hong Kong secondary listing on Friday after the markets close, according to two sources close to the deal.
-
NetEase follows Alibaba’s lead with secondary listing in HK
Chinese online game developer NetEase had covered its HK$21.6bn ($2.8bn) secondary listing in Hong Kong multiple times over by the time GlobalCapital Asia went to press on Thursday. Investors have long awaited the company’s return from the US, pumping in orders as markets rallied despite numerous geopolitical headlines. Jonathan Breen reports.
-
Pacific Insurance gets nod for London IPO, secures cornerstone
China Pacific Insurance (Group) Co has won approval from the mainland securities regulator to move ahead with its stock offering on the London Stock Exchange.
-
Cambricon gets nod for Star IPO after fast approval
Cambricon Technologies Corp is one step closer to debuting on China’s technology-focused Star Board, having received the go-ahead from the bourse in just over two months.
-
Korean casino gaming firm eyes rare US listing
Online casino gaming company DoubleDown Interactive is planning a Nasdaq IPO, the first by a South Korean company in nearly a decade.
-
Dada Nexus kicks off $281m US IPO roadshow
China’s Dada Nexus, an operator of on-demand retail and delivery platforms, has launched bookbuilding for its up to $280.5m US listing, according to a source familiar with the matter.
-
NetEase launches $2.8bn Hong Kong secondary listing
Online game developer NetEase has begun bookbuilding for its long-awaited Hong Kong secondary offering. The company is aiming to raise around HK$21.6bn ($2.8bn).
-
NetEase readies jumbo HK secondary listing
US-listed internet giant NetEase is set to launch its Hong Kong secondary public offering, after getting the green light from the city’s stock exchange.
-
Legend Biotech sets ball rolling on $369m US IPO
Biopharmaceutical company Legend Biotech Corp has kicked off bookbuilding for its Nasdaq IPO of up to $368.5m, according to a source familiar with the matter.
